4.1 Review

Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential

Journal

CHEMISTRY & BIOLOGY
Volume 20, Issue 3, Pages 316-331

Publisher

CELL PRESS
DOI: 10.1016/j.chembiol.2013.02.006

Keywords

-

Funding

  1. Association pour la Recherche curie Cancer (ARC) [3940, SFI20111204054]
  2. Conectus
  3. Labex Medalis
  4. Fondation pour la Recherche Medicale
  5. MNESR

Ask authors/readers for more resources

Prohibitins (PHBs) are scaffold proteins that modulate many signaling pathways controlling cell survival, metabolism, and inflammation. Several drugs that target PHBs have been identified and evaluated for various clinical applications. Preclinical and clinical studies indicate that these PHB ligands may be useful in oncology, cardiology, and neurology, as well as against obesity. This review covers the physiological role of PHBs in health and diseases and current developments concerning PHB ligands.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available